J Cereb Blood Flow MetaboI4:447-457 Dunwiddie TV, Hoffer BJ (1980) Adenine nucleotides and syn aptic transmission in the in vit ro rat hippocampus. Br J Phar macal 69:59-68 Edvinsson L, Fredholm BB (1983) Characterization of adenosine
probably not so, since anoxia increased CBF by 55.5 ± 5 and 71.8 ± 11.8% before and after saline injection in Group I, respectively.
(b) Ta king into account that anoxia in the saline treated group increased CBF by 71.8 ± 11.8% (true control value of the drug-treated group) and that the maximum increase of CBF was 90.6 ± 26% after EHNA treatment, whereas deoxycoformycin failed to alter the CBF increasing potency of anoxia, the conclusion that adenosine deaminase inhibitors en hance hypoxic hyperemia does not seem warranted. (d) According to our studies (Dora et aI., 1984; Dora, 1985a) carried out on the brain cortex of chlo ralose anaesthetized cats, topically applied adeno sine deaminase and theophylline or systemic the ophylline treatment did not attenuate the CBF in creasing potency of arterial hypoxia.
A minor point is that some of the data from lit erature and some of their own data were misinter preted by Phillis et al. For example, the authors stated, "The threshold for adenosine's relaxant ef fect on vascular smooth muscle lies at � 1 /l-M . . ." (Phillis et aI., 1985, p 295) . Contrary to this, topi cally (Kovach et aI., 1983) or perivascularly (Wahl and Kuschinsky, 1976) applied adenosine dilatates pial and intracortical arterioles at concentrations of 0.01 /l-M. Actually, 1 /l-M 2-chloroadenosine in creases CBF by �40% (Dora, 1985b) .
Furthermore, although deoxycoformycin failed to alter resting CBF significantly, Phillis et al. (1985) stated that it increased basal flow rate slightly. In this context, I may remark that neither adenosine deaminase nor theophylline alter resting CBF (Emerson and Raymond, 1981; Dora et aI., 1984; Dora, 1985a) . 1983) . Adenosine levels increased rapidly in brain during profound ischemia (Winn et aI., 1979) and
hypoxia (Winn et aI., 1981) . During a brief (30 s) period of hypoxia, brain adenosine levels increased sixfold (Winn et aI., 1981) . The levels of extracel lular adenosine in the rat brain reflect the increased adenosine concentrations observed during hypoxia.
As measured with an implanted perfused dialysis tube in the caudate nucleus, extracellular adenosine levels in the norm oxic brain are likely to be 1-2 /l-M (Zetterstrom et al., 1982) . These levels increase three-to fourfold during and following a period of hypoxia. The levels are increased even further fol lowing administration of an adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA). These findings of Zetterstrom et aI. (1982) sharply contradict the assumption that adenosine levels in the perivascular space are <10-8 M (Dora et aI., 1984) and place the adenosine concentrations well into the vasoactive range.
Adenosine deaminase attenuates the response of the cerebral resistance vessels to hypoxia. In cats with cranial windows, Wei and Kontos (1981) ob served that adenosine deaminase, applied topically, produced a marked reduction in hypoxia-induced dilation of small and large pial arterioles.
Pharmacological findings also implicate adeno sine as a coupling factor linking metabolism to CBF.
Theophylline, an adenosine antagonist, reduced the hypoxia-induced increase in CBF observed in dogs and rats (Emerson and Raymond, 1981; Morii et aI., 1984) . Caffeine, another adenosine antagonist, re duced the anoxia-induced increase in CBF in our rat model (Phillis et aI., 1984) . Caffeine reduced both the peak increase in flow and the duration of the anoxia-induced hyperemia. Conversely inhibitors of adenosine transport, dipyridamole, papaverine, and lidoflazine, enhanced the peak increase in flow and/or the duration of the hyperemia in our rat CBF model (Phillis et aI., 1984; 1985b) . Heistad et al. 
